Pharmacokinetics of progesterone a few other countries under the brand name Progestasert. It was marketed between 1976 and 2001. The IUD was never widely used due to a relatively high contraceptive failure rate of 2.9% and the requirement of annual replacement. It contained 38 mg progesterone and released 65 μg progesterone into the uterus per day (adding up to about 35 mg after one year). For comparison, a woman's body produces on average about 25 mg progesterone per day during the luteal phase. While effective as a form of contraception and for decreasing menstrual bleeding and discomfort, long-lived IUDs can fundamentally only deliver
Menstrual synchrony there was no evidence the women in this study synchronized their menstrual cycles. Ziomkiewicz conducted a study with 99 Polish college women living in two dormitories. Thirty six of the women lived in 18 double rooms and sixty three lived in 21 triple rooms. Women recorded their menstrual cycle onsets on menstrual calendars provided to them and 181 days' worth of menstrual cycle data were collected. The mean menstrual cycle length was 30.5 days (SD = 4.56). Based on the mean cycle length of the women in this study, the expected difference by chance in menstrual cycle onset was approximately